#USA #Irvine #Danaher #Masimo #Tim Benner

Tim Benner Takes the Helm at Masimo

In a significant move signaling the future direction of Masimo, the innovative leader in diagnostic solutions, Tim Benner has been appointed as the company’s president effective August 3, 2026. This change comes at a pivotal moment for Masimo, a subsidiary of Danaher, known predominantly for its sophisticated pulse oximetry and patient monitoring solutions. Tim's trajectory at Masimo began in June 2025, and since then, he has made substantial contributions to the company’s strategic planning, customer relations, and ongoing transition following its acquisition by Danaher.

Benner’s previous roles included that of Chief Marketing and Strategy Officer, followed by his recent position of Chief Commercial Officer, where he was integral in leading the global business organization, expanding marketing initiatives, and enhancing customer engagement efforts. His appointment as president reflects the confidence held by senior leadership of both Masimo and Danaher in his capabilities to steer the firm towards a new era of growth and innovation.

Julie Sawyer Montgomery, the designated CEO of Danaher Corporation, expressed her enthusiasm for Benner's leadership, stating, "Tim is an experienced leader who has helped implement measures for long-term success at Masimo. His strategic leadership, deep customer knowledge, and commitment to innovation make him the ideal candidate to lead Masimo as it embarks on this next chapter."

With over 30 years of experience in medical technology management, Benner previously held senior positions at renowned companies such as Edwards Lifesciences, Abbott, Terumo, and Inari Medical/Stryker. His career has been marked by his ability to establish high-performing teams, enhance commercial excellence, and grant healthcare professionals access to innovative technologies that benefit patients globally.

In Benner's own words, he stated, “It is an honor to serve as president of Masimo. For over three decades, Masimo has gained the trust of healthcare professionals worldwide by developing groundbreaking technologies that enhance patient care. As a Danaher company, we have a tremendous opportunity to continue this momentum by combining Masimo’s innovative spirit with the power of the Danaher Business System. I look forward to collaborating with our talented team members and customers to continue delivering meaningful innovations that enhance patient outcomes globally.”

As president, Benner will oversee Masimo’s global operations, focusing on driving innovation across the company’s extensive range of patient monitoring products, enhancing customer partnerships, propelling commercial growth, and advancing Masimo’s mission to improve patient outcomes through cutting-edge technology.

About Masimo

Masimo is renowned for being a pioneer in specialized diagnostic solutions, particularly in pulse oximetry and patient monitoring systems. The company develops a vast array of advanced monitoring technologies, including innovative measurement systems, sensors, patient monitors, and solutions for automation and connectivity. Their mission is to empower healthcare professionals to transform patient care effectively. Masimo's SET® pulse oximetry technology, which launched in 1995, has been demonstrated to outperform other pulse oximetry technologies in over 100 independent studies and is reportedly used on more than 200 million patients annually worldwide. Most notably, the Masimo SET® is recognized as a pulse oximetry system of choice in the top ten U.S. hospitals as per Newsweek’s 2026 ranking of the World’s Best Hospitals.

For further information about Masimo and its innovative products, visit their official site.

About Danaher

Danaher is a global leader in life sciences and diagnostics, dedicated to leveraging science and technology to improve human health. With a comprehensive ecosystem of industry-leading enterprises, Danaher partners closely with clients to tackle some of their most complex scientific and clinical challenges, aiding in the swift transition of innovations from discovery to market, which ultimately benefits patients. With continuous improvement and operational excellence, Danaher’s more than 60,000 employees worldwide are committed to making a sustainable impact and enhancing quality of life globally, all while building a healthier and more sustainable future. To learn more, visit Danaher’s site.